Comera Life Sciences Holdings, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Comera Life Sciences Holdings, Inc. reported Increase (Decrease) in Prepaid Expense and Other Assets of -$771.67 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2023-11-09
- Comera Life Sciences Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-09-30 was -$210.09K.
- Comera Life Sciences Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-06-30 was -$443.86K, a 237.81% decline year-over-year.
- Comera Life Sciences Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-03-31 was -$117.72K.
- Comera Life Sciences Holdings, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-12-31 was -$339.25K, a 257.88% decline year-over-year.
- Comera Life Sciences Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$800.15K, a 446.45% decline from fiscal 2021.
- Comera Life Sciences Holdings, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2021 was $230.96K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$210.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$653.96K derived: sum of 2 quarters · filed 2023-11-09 | -$771.67K 10-Q · filed 2023-11-09 | -$1.11M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | -$443.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$561.58K 10-Q · filed 2023-08-10 | -$900.83K derived: sum of 3 quarters · filed 2023-08-10 | -$1.46M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | -$117.72K 10-Q · filed 2023-05-12 | -$456.97K derived: sum of 2 quarters · filed 2023-05-12 | -$1.02M derived: sum of 3 quarters · filed 2023-11-09 | -$697.19K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | -$339.25K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | -$901.56K derived: sum of 2 quarters · filed 2023-11-09 | -$579.47K derived: sum of 3 quarters · filed 2023-11-09 | -$800.15K 10-K · filed 2023-03-17 |
| 2022-09-30 | -$562.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$240.22K derived: sum of 2 quarters · filed 2023-11-09 | -$460.89K 10-Q · filed 2023-11-09 | -$246.01K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $322.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $101.41K 10-Q · filed 2023-08-10 | $316.30K derived: sum of 3 quarters · filed 2023-08-10 | $321.56K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$220.68K 10-Q · filed 2023-05-12 | -$5.79K derived: sum of 2 quarters · filed 2023-05-12 | -$527.00 derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | $214.89K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $220.15K derived: sum of 2 quarters · filed 2023-03-17 | $230.96K 10-K · filed 2023-03-17 | |
| 2021-09-30 | $5.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $16.07K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $10.81K 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $583.00 8-K · filed 2022-09-06 |